Fourth branchial cleft anomaly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:141037Q18.0
Who is this for?
Show terms as
1FDA treatments9Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Fourth branchial cleft anomaly (also known as fourth branchial pouch anomaly, fourth pharyngeal arch anomaly, or fourth branchial cleft cyst/sinus/fistula) is a rare congenital malformation arising from incomplete obliteration of the fourth branchial apparatus during embryonic development. These anomalies are among the rarest of all branchial cleft defects, accounting for a very small proportion of branchial anomalies. The condition primarily affects the neck and may involve the thyroid gland, pyriform sinus (a recess in the throat), and surrounding structures of the lower neck. Clinically, fourth branchial cleft anomalies most commonly present as recurrent neck abscesses, acute suppurative thyroiditis (infected and inflamed thyroid gland), or a sinus tract that typically courses from the pyriform sinus apex downward through the neck, often on the left side. Patients may experience recurrent episodes of neck swelling, pain, fever, and difficulty swallowing. In neonates and infants, the anomaly may present as respiratory distress or a neck mass. The condition can be misdiagnosed as a thyroid abscess or other neck pathology, leading to delayed diagnosis. Diagnosis is established through imaging studies such as CT scan, MRI, or barium swallow demonstrating a tract originating from the pyriform sinus. Direct laryngoscopy may also reveal the internal opening. Treatment is primarily surgical, involving complete excision of the sinus tract or fistula to prevent recurrence. In some cases, endoscopic cauterization or chemocauterization of the internal opening in the pyriform sinus has been used as a less invasive alternative. Acute infections are managed with antibiotics and drainage prior to definitive surgical repair. Recurrence is possible if the tract is not completely removed.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Jun 2020

MYCAPSSA (formerly Octreolin): FDA approved

Mycapssa (octreotide) is indicated for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

MYCAPSSA (formerly Octreolin)

octreotide (oral)· Chiesi USA, Inc.Orphan Drug

Mycapssa (octreotide) is indicated for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.

No actively recruiting trials found for Fourth branchial cleft anomaly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Fourth branchial cleft anomaly community →

Specialists

9 foundView all specialists →
KS
Kateřina Sobotková
Specialist
1 Fourth branchial cleft anomaly publication
MU
Milan Urík
Specialist
1 Fourth branchial cleft anomaly publication
KP
Klára Perce
Specialist
1 Fourth branchial cleft anomaly publication
BP
Barbora Petrová
Specialist
1 Fourth branchial cleft anomaly publication
S&
Soňa Šikolová
Specialist
1 Fourth branchial cleft anomaly publication
MB
Michal Bartoš
Specialist
1 Fourth branchial cleft anomaly publication
JJ
Jana Jančíková
Specialist
1 Fourth branchial cleft anomaly publication
RK
Roman Kula
Specialist
1 Fourth branchial cleft anomaly publication
PJ
Petr Jabandžiev
Specialist
1 Fourth branchial cleft anomaly publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
MYCAPSSA (formerly Octreolin)(octreotide (oral))Chiesi USA, Inc.

Travel Grants

No travel grants are currently matched to Fourth branchial cleft anomaly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Fourth branchial cleft anomalyForum →

No community posts yet. Be the first to share your experience with Fourth branchial cleft anomaly.

Start the conversation →

Latest news about Fourth branchial cleft anomaly

No recent news articles for Fourth branchial cleft anomaly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Fourth branchial cleft anomaly

What is Fourth branchial cleft anomaly?

Fourth branchial cleft anomaly (also known as fourth branchial pouch anomaly, fourth pharyngeal arch anomaly, or fourth branchial cleft cyst/sinus/fistula) is a rare congenital malformation arising from incomplete obliteration of the fourth branchial apparatus during embryonic development. These anomalies are among the rarest of all branchial cleft defects, accounting for a very small proportion of branchial anomalies. The condition primarily affects the neck and may involve the thyroid gland, pyriform sinus (a recess in the throat), and surrounding structures of the lower neck. Clinically, f

How is Fourth branchial cleft anomaly inherited?

Fourth branchial cleft anomaly follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Fourth branchial cleft anomaly?

9 specialists and care centers treating Fourth branchial cleft anomaly are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Fourth branchial cleft anomaly?

1 patient support program are currently tracked on UniteRare for Fourth branchial cleft anomaly. See the treatments and support programs sections for copay assistance, eligibility, and contact details.